3.16
Collplant Biotechnologies Ltd Borsa (CLGN) Ultime notizie
Collplant stock hits 52-week low at $3.07 amid market challenges By Investing.com - Investing.com South Africa
Collplant stock hits 52-week low at $3.07 amid market challenges - Investing.com India
Collplant stock hits 52-week low at $3.24 amid market challenges - Investing.com India
Collplant stock hits 52-week low at $3.24 amid market challenges By Investing.com - Investing.com South Africa
Israel-based CollPlant expands distribution for VergenixSTR in Europe and Asia - BSA bureau
CollPlant expands VergenixSTR distribution in Europe and Asia By Investing.com - Investing.com Australia
CollPlant expands European and Asian distribution of soft tissue repair matrix - Yahoo Finance
CollPlant Expands Vergenix STR Distribution Across Europe And Asia - Nasdaq
Medical Breakthrough: CollPlant's Tendon Treatment Enters 4 New MarketsWhy It Matters - StockTitan
D. Boral Capital Reaffirms “Buy” Rating for CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World
CollPlant secures U.S. patent for dermal filler - Investing.com India
CollPlant secures U.S. patent for dermal filler By Investing.com - Investing.com Australia
CollPlant Biotechnologies Provides a Corporate Update - PR Newswire
Tissue Engineering Market: Key Player Profiles, Industry US$ - openPR
CollPlant Biotechnologies (NASDAQ:CLGN) Earns Buy Rating from D. Boral Capital - Defense World
Contrasting CollPlant Biotechnologies (NASDAQ:CLGN) and Pathfinder Cell Therapy (OTCMKTS:PFND) - Defense World
CLGN (CollPlant Biotechnologies) 50-Day SMA : $4.31 (As of Dec. 01, 2024) - GuruFocus.com
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2024 Earnings Call Transcript - MSN
CLGNCollPlant Biotechnologies Ltd Ordinary Shares Latest Stock News & Market Updates - StockTitan
CollPlant Biotechnologies Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highl - GuruFocus.com
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highlights: Navigating Revenue ... - Yahoo Finance
CollPlant Biotechnologies’ Q3 2024 Financial Update - TipRanks
Q3 2024 Collplant Biotechnologies Ltd Earnings Call Transcript - GuruFocus.com
CollPlant Issues Letter to Shareholders - GuruFocus.com
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PR Newswire
What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings - GuruFocus.com
Collplant stock hits 52-week low at $3.56 amid market challenges - Investing.com Canada
Collplant stock hits 52-week low at $3.56 amid market challenges By Investing.com - Investing.com South Africa
CollPlant Biotechnologies (CLGN) Set to Announce Earnings on Wednesday - Defense World
CollPlant (CLGN) to Report Q3 2024 Earnings on Nov 27: Conference Call Details | CLGN Stock News - StockTitan
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION – Company AnnouncementFT.com - Financial Times
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - PR Newswire
Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Invest In Growth - Yahoo Finance
Collplant stock hits 52-week low at $3.61 amid market challenges - Investing.com Australia
500: Something went wrong - Investing.com India
Collplant stock hits 52-week low at $3.75 amid market challenges - Investing.com Australia
EF Hutton Initiates Coverage of CollPlant Biotechnologies (CLGN) with Buy Recommendation - MSN
Collplant stock hits 52-week low at $4.05 amid market challenges - Investing.com India
Collplant stock hits 52-week low at $4.05 amid market challenges By Investing.com - Investing.com South Africa
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):